新闻专区

Burning Rock Receives CE Mark for its OverC™ Multi-Cancer Detecti...

Var Date：2022-05-20

Burning Rock announced that it has received CE marking for its OverC™ Multi-Cancer Detection Blood Test manufactured in both the US and...

More

Burning Rock Receives CE Mark Approval for Three NGS Tumor Kits

Var Date：2022-05-07

Burning Rock announced that the Company had received CE mark approval for three self-developed next generation sequencing (NGS) kits, n...

More

Burning Rock Secures Second NGS Kit Approval from the NMPA

Var Date：2022-03-15

Burning Rock announced that the National Medical Products Administration (NMPA) approved Burning Rock's Human Nine-Gene Mutation Joint ...

More

Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Li...

Var Date：2021-11-18

GUANGZHOU, China, Nov. 17, 2021– Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategi...

More

Burning Rock and IMPACT Therapeutics Announce a Global Strategic ...

Var Date：2021-08-03

Burning Rock today announced a global strategic partnership with IMPACT Therapeutics in companion diagnostics (CDx) development for a p...

More

Burning Rock and Abbisko Therapeutics Announce Strategic Partners...

Var Date：2021-04-29

The two companies will work together to develop a CDx assay for ABSK091 (formerly known as AZD4547) to advance clinical research and de...

More

Burning Rock Announces an Exclusive in-Licensing of a Risk Strati...

Var Date：2021-03-02

This agreement will bring DetermaRx™, a risk stratification test for early stage lung cancer patients, to China.

More

Var Date：2021-03-02

Burning Rock announced that it entered into a development and commercialization agreement with Myriad which will bring myChoice® tumor ...

More

Burning Rock and CStone Pharmaceuticals reached a strategic colla...

Var Date：2020-06-29

Burning Rock's close cooperation with CStone is expected to promote the standardization of RET gene testing in China.

More

Burning Rock deepens cooperation with Illumina to promote develop...

Var Date：2020-05-12

Burning Rock and Illumina jointly announced today that they are joining forces to promote the development and standardization of NGS-ba...

More

Burning Rock initiates the first prospective, multi-center pan-ca...

Var Date：2020-05-07

Burning Rock today announces the initiation of its 14,000 patient PREDICT (Pan-CanceR Early DetectIon ProjeCT) study to further develop...

More

Burning Rock Dx Launches Magnis BR to Innovate Total Process Auto...

Var Date：2019-11-18

Exclusively supported by Agilent, this futuristic technology brings NGS testing to more hospitals

More

Burning Rock announces the completion of the Series C financing o...

Var Date：2019-08-23

On February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 milli...

More

China's first NGS cancer testing kit made by Burning Rock Dx and ...

Var Date：2019-08-26

On July 23, 2018, National Medical Products Administration (NMPA) vetted and granted a license to Burning Rock Biotech(Guang Zhou) Co.,...

More

Burning Rock Dx Honored with 2018 Guangzhou Hi-tech “Unicorn” and...

Var Date：2019-08-25

Burning Rock and other firms were rated as 2018 hi-tech unicorns in Guangzhou. Besides, Burning Rock was also included into the top ten...

More

Burning Rock Dx Certified by the Certification of ISO 13485 Quali...

Var Date：2019-08-23

Lately Burning Rock Dx successfully passed certification of the ISO 13485 Quality Management System and received the corresponding cert...

More

Burning Rock and Illumina Collaborate on Molecular Diagnostics fo...

Var Date：2019-10-10

August 24, 2015—Burning Rock and Illumina, Inc.(NASDAQ: ILMN) today announced they have entered into an agreement whereby Burning Rock ...

More

Copyright © 2015-2022 燃石医学版权所有粤ICP备14067392号